Maintenance of pathogenic Th2 cells in allergic disorders

Allergology International

Volumn 66, Issue 3, 2017, Pages 369-376

  Shinoda, Kenta ^a,b   Hirahara, Kiyoshi ^a   Nakayama, Toshinori ^a,c  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Allergy; IL 7; Inducible bronchus associated lymphoid tissue (iBALT); Lymphatic endothelial cells (LECs); Pathogenic Th2 (Tpath2) cells

Indexed keywords

ALLERGY; CHRONIC RHINOSINUSITIS; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; LYMPHOCYTE FUNCTION; LYMPHOID TISSUE; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL; ANIMAL; CELL COMMUNICATION; CHRONIC DISEASE; HYPERSENSITIVITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MUCOSAL-ASSOCIATED INVARIANT T CELL; PATHOLOGY; RESPIRATORY TRACT ALLERGY; T LYMPHOCYTE SUBPOPULATION;

ALLERGEN;

ALLERGENS; ANIMALS; CELL COMMUNICATION; CHRONIC DISEASE; ENDOTHELIAL CELLS; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC MEMORY; MUCOSAL-ASSOCIATED INVARIANT T CELLS; RESPIRATORY HYPERSENSITIVITY; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

EID: 85017167868     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.1016/j.alit.2017.03.005     Document Type: Review

References (76)

1. Holgate, S.T., Innate and adaptive immune responses in asthma. Nat Med 18 (2012), 673–683.
2. Pepper, M., Linehan, J.L., Pagan, A.J., Zell, T., Dileepan, T., Cleary, P.P., et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol 11 (2010), 83–89.
3. Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L., et al. Interleukin-13: central mediator of allergic asthma. Science 282 (1998), 2258–2261.
4. Zhu, Z., Lee, C.G., Zheng, T., Chupp, G., Wang, J., Homer, R.J., et al. Airway inflammation and remodeling in asthma. Lessons from interleukin 11 and interleukin 13 transgenic mice. Am J Respir Crit Care Med 164 (2001), S67–S70.
5. Blackburn, M.R., Lee, C.G., Young, H.W., Zhu, Z., Chunn, J.L., Kang, M.J., et al. Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 112 (2003), 332–344.
6. Nakayama, T., Hirahara, K., Onodera, A., Endo, Y., Hosokawa, H., Shinoda, K., et al. Th2 cells in health and disease. Annu Rev Immunol 35 (2017), 53–84.
7. Endo, Y., Iwamura, C., Kuwahara, M., Suzuki, A., Sugaya, K., Tumes, D.J., et al. Eomesodermin controls interleukin-5 production in memory T helper 2 cells through inhibition of activity of the transcription factor GATA3. Immunity 35 (2011), 733–745.
8. Islam, S.A., Chang, D.S., Colvin, R.A., Byrne, M.H., McCully, M.L., Moser, B., et al. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat Immunol 12 (2011), 167–177.
9. Upadhyaya, B., Yin, Y., Hill, B.J., Douek, D.C., Prussin, C., Hierarchical IL-5 expression defines a subpopulation of highly differentiated human Th2 cells. J Immunol 187 (2011), 3111–3120.
10. Lanzavecchia, A., Santini, P., Maggi, E., Del Prete, G.F., Falagiani, P., Romagnani, S., et al. In vitro selective expansion of allergen specific T cells from atopic patients. Clin Exp Immunol 52 (1983), 21–28.
11. Mojtabavi, N., Dekan, G., Stingl, G., Epstein, M.M., Long-lived Th2 memory in experimental allergic asthma. J Immunol 169 (2002), 4788–4796.
12. Cohn, L., Elias, J.A., Chupp, G.L., Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22 (2004), 789–815.
13. Paul, W.E., Zhu, J., How are T(H)2-type immune responses initiated and amplified?. Nat Rev Immunol 10 (2010), 225–235.
14. Sallusto, F., Lenig, D., Forster, R., Lipp, M., Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999), 708–712.
15. Mueller, S.N., Gebhardt, T., Carbone, F.R., Heath, W.R., Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 31 (2013), 137–161.
16. Schenkel, J.M., Masopust, D., Tissue-resident memory T cells. Immunity 41 (2014), 886–897.
17. Turner, D.L., Bickham, K.L., Thome, J.J., Kim, C.Y., D'Ovidio, F., Wherry, E.J., et al. Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunol 7 (2014), 501–510.
18. Teijaro, J.R., Turner, D., Pham, Q., Wherry, E.J., Lefrancois, L., Farber, D.L., Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol 187 (2011), 5510–5514.
19. Gebhardt, T., Whitney, P.G., Zaid, A., Mackay, L.K., Brooks, A.G., Heath, W.R., et al. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature 477 (2011), 216–219.
20. Glennie, N.D., Yeramilli, V.A., Beiting, D.P., Volk, S.W., Weaver, C.T., Scott, P., Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection. J Exp Med 212 (2015), 1405–1414.
21. Sakai, S., Kauffman, K.D., Schenkel, J.M., McBerry, C.C., Mayer-Barber, K.D., Masopust, D., et al. Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells. J Immunol 192 (2014), 2965–2969.
22. Shin, H., Iwasaki, A., A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 491 (2012), 463–467.
23. Shinoda, K., Hirahara, K., Iinuma, T., Ichikawa, T., Suzuki, A.S., Sugaya, K., et al. Thy1+IL-7+ lymphatic endothelial cells in iBALT provide a survival niche for memory T-helper cells in allergic airway inflammation. Proc Natl Acad Sci U S A 113 (2016), E2842–E2851.
24. Hondowicz, B.D., An, D., Schenkel, J.M., Kim, K.S., Steach, H.R., Krishnamurty, A.T., et al. Interleukin-2-Dependent allergen-specific tissue-resident memory cells drive asthma. Immunity 44 (2016), 155–166.
25. Corris, P.A., Dark, J.H., Aetiology of asthma: lessons from lung transplantation. Lancet 341 (1993), 1369–1371.
26. Grotenboer, N.S., Ketelaar, M.E., Koppelman, G.H., Nawijn, M.C., Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology. J Allergy Clin Immunol 131 (2013), 856–865.
27. Tamari, M., Tanaka, S., Hirota, T., Genome-wide association studies of allergic diseases. Allergol Int 62 (2013), 21–28.
28. Iijima, K., Kobayashi, T., Hara, K., Kephart, G.M., Ziegler, S.F., McKenzie, A.N., et al. IL-33 and thymic stromal lymphopoietin mediate immune pathology in response to chronic airborne allergen exposure. J Immunol 193 (2014), 1549–1559.
29. Christianson, C.A., Goplen, N.P., Zafar, I., Irvin, C., Good, J.T. Jr., Rollins, D.R., et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol, 136, 2015 59–68. e14.
30. Endo, Y., Hirahara, K., Iinuma, T., Shinoda, K., Tumes, D.J., Asou, H.K., et al. The interleukin-33-p38 kinase axis confers memory T helper 2 cell pathogenicity in the airway. Immunity 42 (2015), 294–308.
31. Sminia, T., van der Brugge-Gamelkoorn, G.J., Jeurissen, S.H., Structure and function of bronchus-associated lymphoid tissue (BALT). Crit Rev Immunol 9 (1989), 119–150.
32. Moyron-Quiroz, J.E., Rangel-Moreno, J., Kusser, K., Hartson, L., Sprague, F., Goodrich, S., et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 10 (2004), 927–934.
33. Randall, T.D., Bronchus-associated lymphoid tissue (BALT) structure and function. Adv Immunol 107 (2010), 187–241.
34. Vroman, H., Bergen, I.M., Li, B.W., van Hulst, J.A., Lukkes, M., van Uden, D., et al. Development of eosinophilic inflammation is independent of B-T cell interaction in a chronic house dust mite-driven asthma model. Clin Exp Allergy 47 (2017), 551–564.
35. Hwang, J.Y., Randall, T.D., Silva-Sanchez, A., Inducible bronchus-associated lymphoid tissue: taming inflammation in the lung. Front Immunol, 7, 2016, 258.
36. Delventhal, S., Hensel, A., Petzoldt, K., Pabst, R., Effects of microbial stimulation on the number, size and activity of bronchus-associated lymphoid tissue (BALT) structures in the pig. Int J Exp Pathol 73 (1992), 351–357.
37. Tschernig, T., Pabst, R., Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology 68 (2000), 1–8.
38. Carragher, D.M., Rangel-Moreno, J., Randall, T.D., Ectopic lymphoid tissues and local immunity. Semin Immunol 20 (2008), 26–42.
39. Baluk, P., Adams, A., Phillips, K., Feng, J., Hong, Y.K., Brown, M.B., et al. Preferential lymphatic growth in bronchus-associated lymphoid tissue in sustained lung inflammation. Am J Pathol 184 (2014), 1577–1592.
40. Halle, S., Dujardin, H.C., Bakocevic, N., Fleige, H., Danzer, H., Willenzon, S., et al. Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. J Exp Med 206 (2009), 2593–2601.
41. Moyron-Quiroz, J.E., Rangel-Moreno, J., Hartson, L., Kusser, K., Tighe, M.P., Klonowski, K.D., et al. Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 25 (2006), 643–654.
42. Rangel-Moreno, J., Moyron-Quiroz, J.E., Hartson, L., Kusser, K., Randall, T.D., Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. Proc Natl Acad Sci U S A 104 (2007), 10577–10582.
43. Kocks, J.R., Davalos-Misslitz, A.C., Hintzen, G., Ohl, L., Forster, R., Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. J Exp Med 204 (2007), 723–734.
44. GeurtsvanKessel, C.H., Willart, M.A., Bergen, I.M., van Rijt, L.S., Muskens, F., Elewaut, D., et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med 206 (2009), 2339–2349.
45. van Leeuwen, E.M., Sprent, J., Surh, C.D., Generation and maintenance of memory CD4(+) T Cells. Curr Opin Immunol 21 (2009), 167–172.
46. Surh, C.D., Sprent, J., Homeostasis of naive and memory T cells. Immunity 29 (2008), 848–862.
47. Purton, J.F., Tan, J.T., Rubinstein, M.P., Kim, D.M., Sprent, J., Surh, C.D., Antiviral CD4+ memory T cells are IL-15 dependent. J Exp Med 204 (2007), 951–961.
48. Lenz, D.C., Kurz, S.K., Lemmens, E., Schoenberger, S.P., Sprent, J., Oldstone, M.B., et al. IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory. Proc Natl Acad Sci U S A 101 (2004), 9357–9362.
49. Bushar, N.D., Corbo, E., Schmidt, M., Maltzman, J.S., Farber, D.L., Ablation of SLP-76 signaling after T cell priming generates memory CD4 T cells impaired in steady-state and cytokine-driven homeostasis. Proc Natl Acad Sci U S A 107 (2010), 827–831.
50. Riou, C., Yassine-Diab, B., Van grevenynghe, J., Somogyi, R., Greller, L.D., Gagnon, D., et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J Exp Med 204 (2007), 79–91.
51. Gratz, I.K., Truong, H.A., Yang, S.H., Maurano, M.M., Lee, K., Abbas, A.K., et al. Cutting Edge: memory regulatory t cells require IL-7 and not IL-2 for their maintenance in peripheral tissues. J Immunol 190 (2013), 4483–4487.
52. Shinoda, K., Tokoyoda, K., Hanazawa, A., Hayashizaki, K., Zehentmeier, S., Hosokawa, H., et al. Type II membrane protein CD69 regulates the formation of resting T-helper memory. Proc Natl Acad Sci U S A 109 (2012), 7409–7414.
53. Lohning, M., Hegazy, A.N., Pinschewer, D.D., Busse, D., Lang, K.S., Hofer, T., et al. Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. J Exp Med 205 (2008), 53–61.
54. Li, J., Huston, G., Swain, S.L., IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 198 (2003), 1807–1815.
55. Mazzucchelli, R.I., Warming, S., Lawrence, S.M., Ishii, M., Abshari, M., Washington, A.V., et al. Visualization and identification of IL-7 producing cells in reporter mice. PLoS One, 4, 2009, e7637.
56. Tokoyoda, K., Zehentmeier, S., Hegazy, A.N., Albrecht, I., Grun, J.R., Lohning, M., et al. Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity 30 (2009), 721–730.
57. Link, A., Vogt, T.K., Favre, S., Britschgi, M.R., Acha-Orbea, H., Hinz, B., et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 8 (2007), 1255–1265.
58. Withers, D.R., Gaspal, F.M., Mackley, E.C., Marriott, C.L., Ross, E.A., Desanti, G.E., et al. Cutting edge: lymphoid tissue inducer cells maintain memory CD4 T cells within secondary lymphoid tissue. J Immunol 189 (2012), 2094–2098.
59. Hara, T., Shitara, S., Imai, K., Miyachi, H., Kitano, S., Yao, H., et al. Identification of IL-7-producing cells in primary and secondary lymphoid organs using IL-7-GFP knock-in mice. J Immunol 189 (2012), 1577–1584.
60. Zamisch, M., Moore-Scott, B., Su, D.M., Lucas, P.J., Manley, N., Richie, E.R., Ontogeny and regulation of IL-7-expressing thymic epithelial cells. J Immunol 174 (2005), 60–67.
61. Matsue, H., Bergstresser, P.R., Takashima, A., Keratinocyte-derived IL-7 serves as a growth factor for dendritic epidermal T cells in mice. J Immunol 151 (1993), 6012–6019.
62. Sawa, Y., Arima, Y., Ogura, H., Kitabayashi, C., Jiang, J.J., Fukushima, T., et al. Hepatic interleukin-7 expression regulates T cell responses. Immunity 30 (2009), 447–457.
63. Malhotra, D., Fletcher, A.L., Astarita, J., Lukacs-Kornek, V., Tayalia, P., Gonzalez, S.F., et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol 13 (2012), 499–510.
64. Endo, Y., Nakayama, T., Pathogenic Th2 (Tpath2) cells in airway inflammation. Oncotarget 6 (2015), 32303–32304.
65. Steinfelder, S., Rausch, S., Michael, D., Kuhl, A.A., Hartmann, S., Intestinal helminth infection induces highly functional resident memory CD4+ T cells in mice. Eur J Immunol 47 (2017), 353–363.
66. Garg, A., Das-Bhaumik, R., Nesbitt, A.D., Levene, A.P., Joshi, N., Grant, W.E., et al. Visual loss secondary to eosinophilic mucin rhinosinusitis in a woman: a case report. J Med Case Rep, 4, 2010, 350.
67. Ferguson, B.J., Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope 110 (2000), 799–813.
68. Ponikau, J.U., Sherris, D.A., Kephart, G.M., Kern, E.B., Gaffey, T.A., Tarara, J.E., et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma?. J Allergy Clin Immunol 112 (2003), 877–882.
69. Bachert, C., Vignola, A.M., Gevaert, P., Leynaert, B., Van Cauwenberge, P., Bousquet, J., Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin North Am 24 (2004), 19–43.
70. Stevens, W.W., Ocampo, C.J., Berdnikovs, S., Sakashita, M., Mahdavinia, M., Suh, L., et al. Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease. Am J Respir Crit Care Med 192 (2015), 682–694.
71. Steinke, J.W., Liu, L., Huyett, P., Negri, J., Payne, S.C., Borish, L., Prominent role of IFN-gamma in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol, 132, 2013 856–65. e1-3.
72. Bachert, C., Wagenmann, M., Hauser, U., Rudack, C., IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 99 (1997), 837–842.
73. Lam, E.P., Kariyawasam, H.H., Rana, B.M., Durham, S.R., McKenzie, A.N., Powell, N., et al. IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa. J Allergy Clin Immunol 137 (2016), 1514–1524.
74. Iinuma, T., Okamoto, Y., Yamamoto, H., Inamine-Sasaki, A., Ohki, Y., Sakurai, T., et al. Interleukin-25 and mucosal T cells in noneosinophilic and eosinophilic chronic rhinosinusitis. Ann Allergy Asthma Immunol 114 (2015), 289–298.
75. Zhang, Y.N., Song, J., Wang, H., Wang, H., Zeng, M., Zhai, G.T., et al. Nasal IL-4(+)CXCR5(+)CD4(+) T follicular helper cell counts correlate with local IgE production in eosinophilic nasal polyps. J Allergy Clin Immunol 137 (2016), 462–473.
76. Ortega, H.G., Liu, M.C., Pavord, I.D., Brusselle, G.G., FitzGerald, J.M., Chetta, A., et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 371 (2014), 1198–1207.